These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26619898)

  • 1. How many carbonic anhydrase inhibition mechanisms exist?
    Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(3):345-60. PubMed ID: 26619898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.
    Nocentini A; Angeli A; Carta F; Winum JY; Zalubovskis R; Carradori S; Capasso C; Donald WA; Supuran CT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):561-580. PubMed ID: 33615947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
    De Simone G; Alterio V; Supuran CT
    Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.
    Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery.
    Nocentini A; Supuran CT
    Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
    Capasso C; Supuran CT
    Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of carbonic anhydrases.
    Supuran CT
    Biochem J; 2016 Jul; 473(14):2023-32. PubMed ID: 27407171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II.
    Alp C; Maresca A; Alp NA; Gültekin MS; Ekinci D; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):294-8. PubMed ID: 22380772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
    Pastorekova S; Parkkila S; Pastorek J; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
    J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.
    Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?
    Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):485-495. PubMed ID: 29390912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.
    Winum JY; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):321-4. PubMed ID: 24939097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1583-7. PubMed ID: 18242985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery.
    Supuran CT
    Expert Opin Drug Discov; 2020 Jun; 15(6):671-686. PubMed ID: 32208982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
    Vullo D; Del Prete S; Osman SM; De Luca V; Scozzafava A; Alothman Z; Supuran CT; Capasso C
    Bioorg Med Chem Lett; 2014 Jan; 24(1):275-9. PubMed ID: 24314394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.
    Maresca A; Temperini C; Vu H; Pham NB; Poulsen SA; Scozzafava A; Quinn RJ; Supuran CT
    J Am Chem Soc; 2009 Mar; 131(8):3057-62. PubMed ID: 19206230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.